Skip to content

Dr. B. Moerenhout

Active
Private limited companyfounded 2012active for 14 yearsMeesberg 36, 3220 Holsbeek, BelgiumKBO/BCE: BE 0848.958.351
Summary

Dr. B. Moerenhout has been active since 2012 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €1.5m and a net result of €506,250. Equity has been stable since 2018 (±1.6% per year). Its solvency ranks better than 59% of 3,024 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Official details

Source: KBO
Status
Active since 25-09-2012 Normal situation
Activity
Specialist medical practice NACE 86220
Establishment unit
2.213.261.272 3220 Holsbeek, since 25-09-2012
Financial year end
31 December
Peppol
Reachable

Board and ownership

Board

Financial position

97 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Annual accounts 2025
Gross margin
€781,891
▲ 42.6%
Turnover
≈ €1.5m
estimated
Profit
€506,250
▲ 44.6%
Equity
€1.5m
▲ 26.3%
Total assets
€2.2m
▲ 16.4%
  • 2025 accounts filed 31 days after the deadline
Filed on 31-08-2026
Score breakdownraises riskLast filed accounts filed 31 days late; 1 of the last 3 accounts latelowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 2.81, cash €1.1mSize: total assets €2.2mShow the evidence

Checked score

Score 2025
97 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 77% of small companies in human health (NACE 86)
Financial strength · tick: 2024
Strong
Solvency 94+6
equity 68.6% of total assets
Liquidity 87+40
short-term debt 31.4% · cash 50.2%
Profitability 98+6
return on assets 23.4%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (1,079 companies, NACE 86, small)
Last 24 months 12-2024: < 0.1% 01-2025: < 0.1%● unchanged vs 12-2024lowest value 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: 0.1%▲ +0.1 percentage points vs 07-2026highest value 09-2026: < 0.1%▼ -0.1 percentage points vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026 11-2026: < 0.1%● unchanged vs 10-2026
Credit of up to €140,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 2.81 (2.35 in 2024), above the usual 1.5. Short-term debt is 31.4% and cash 50.2% of total assets. 31.4% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, small). It does better than 46% of them on solvency, 80% on liquidity, 94% on profitability and 88% on growth.

The bankruptcy probability was computed on 01-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Six signals.
lowers riskraises riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Liquidity: current ratio 2.81, cash €1.1m
NBB · annual accounts
lowers risk · Size: total assets €2.2m
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
raises risk · Last filed accounts filed 31 days late; 1 of the last 3 accounts late
NBB · filings
lowers risk · Growing equity
Reported equity is higher than in 2023 and did not fall compared with 2024. These amounts do not establish the cause of the change.
NBB · annual accounts 2025
Equity per financial year
1819202122232425
2018 to 2025 · latest year €1.5m
neutral · A punctual record breaks
This company filed 6 consecutive financial years on time. The year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 31-08-2026, 31 days late. Weigh it accordingly: of the companies that move to filing 1 to 90 days late, 1.41% are now bankrupt, dissolved or in another special legal status, below the 1.66% of all filers. It is a change in behaviour, not evidence of elevated risk.
NBB · 10 filings
Deviation from the deadline
2025
31 days late
2024
2 days early
2023
on the day
2022
on the day
2021
2 days early
2020
1 day early
2019
11 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 2 days after the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 31 July (4 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
01-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Positive: Higher net result than 88% of companies in human healthsector median €110,769 · 2,990 companies €506,250 View
  • Positive: 8 profitable years in a rowprofit 2025: €506,250 8 years View
  • Positive: Result rose in 2025from €350,114 to €506,250 ▲ 44.6% View

Recent changes

  1. · Gazette deed Resignation: MOERENHOUT Bernard (director)Appointment: MOERENHOUT Bernard (director)
  2. · Gazette deed Incorporation
All 14 events

Comparable companies

These companies have the same main activity as Dr. B. Moerenhout: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €2m and €2.4m, founded between 2011 and 2014.

CompanyTotal assetsGross margin
Dr. B. Moerenhout Holsbeek€2.2m€0.8m
Samuël Auvertin Orthopédie Sint-Genesius-Rode€2.4m€0.8m
DRS. MERMUYS-CARDINAEL Brugge€2.3m€0.7m
Dr. Rudolf Reyniers, Oogheelkunde De Haan€2.0m€0.7m
DRS. WEYNE-MONTÉ Brugge€2.3m€0.7m
DOKTER HENDRICKX PLASTISCHE HEELKUNDE Wemmel€2.4m€0.8m
Dokter Roel Verschooten Keerbergen€2.2m€0.6m
Full comparison

Key facts about Dr. B. Moerenhout

What is the company number of Dr. B. Moerenhout?
The company number of Dr. B. Moerenhout is 0848.958.351. The VAT number is the same number with BE in front: BE 0848.958.351.
Where is Dr. B. Moerenhout based?
The registered office is at Meesberg 36, 3220 Holsbeek.Company details
What does Dr. B. Moerenhout do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of Dr. B. Moerenhout?
The legal form of Dr. B. Moerenhout is Private limited company (BV).
When was Dr. B. Moerenhout founded?
Dr. B. Moerenhout was founded on 25-09-2012.
Is Dr. B. Moerenhout still active?
Yes, Dr. B. Moerenhout is an active enterprise in the KBO register.
How many employees does Dr. B. Moerenhout have?
Dr. B. Moerenhout had an average of 0.3 full-time equivalents in financial year 2019, according to the filed annual accounts.Financials
What is the turnover of Dr. B. Moerenhout?
The turnover in financial year 2025 is ≈ €1.5m. This figure is estimated from the gross margin of €781,891 and 40 comparable companies (NACE 862). It probably lies between €1.0m and €2.4m.
Is Dr. B. Moerenhout profitable?
In financial year 2025, Dr. B. Moerenhout made a profit of €506,250.
Where can I find the annual accounts of Dr. B. Moerenhout?
Dr. B. Moerenhout filed 13 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Dr. B. Moerenhout due?
Dr. B. Moerenhout must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.